Premium

We identified an unusual move by an investment firm in Mirum Pharmaceuticals: the largest target price increase we've recorded for the stock, precisely on a day when the market sold off

Despite the market selling off, three investment firms raised target prices for Mirum stock following the approval of a new drug and positive results in a Phase 3 trial.

By the SpyStocks desk · Oct 8, 2026, 04:46 · 1h ago · 3 min read

The rest of this story is for members

The rest is for members

The story continues: the full timeline, the transaction ranges, and the names the forms carry.

Premium comes through the Telegram channel. Already have a code? Sign in to activate it.

Telegram@TheAmericanDream5

Hot stock alerts, straight to Telegram

Real-time buys, sweeps, and trading halts from the desk. Free to join.

Join the channel

We identified an unusual move by an investment firm in Mirum Pharmaceuticals: the largest target price increase we've recorded for the stock, precisely on a day when the market sold off

The rest is for members

Hot stock alerts, straight to Telegram

Related Stories

Morgan Stanley: SpaceX - a unique buying opportunity

Morgan Stanley: SpaceX - a unique buying opportunity

Micron: analysts expect a 100% surge

Micron: analysts expect a 100% surge

Netskope: the new fund and a 60% surge in the stock

Netskope: the new fund and a 60% surge in the stock